- cafead Aug 15, 2024 at 12:03: PM
via Actuate Therapeutics became the latest biotech to join the Nasdaq this week with a scaled-back IPO that brought in $22.4 million.
The Texas- and Ireland-based company had initially outlined plans in July for a $45.1 million offering but soon reduced this to closer to the $22 million mark.
article source
The Texas- and Ireland-based company had initially outlined plans in July for a $45.1 million offering but soon reduced this to closer to the $22 million mark.
article source